Selective uterine artery embolization is a valid adjuvant treatment of choriocarcinoma: a case report and literature review

Yuying Chen,Tingting Sun,Linjing Yuan,Yucong Huang,Aligu Yusufu,Yang Zhang,Xiaoyan Zhang,Shasha He,Yufeng Ren,Shuzhong Yao,Guofen Yang
DOI: https://doi.org/10.3389/fonc.2024.1479603
IF: 4.7
2024-11-13
Frontiers in Oncology
Abstract:Background: Cervical choriocarcinoma is an extremely rare malignancy that is often misdiagnosed due to its nonspecific symptoms, such as vaginal bleeding. Case report: A 39-year-old female presented to the emergency department of the First Affiliated Hospital of Sun Yat-sen University with vaginal bleeding and a serum β-human chorionic gonadotropin (β-HCG) level of 229,386 mIU/mL. Initially, she was misdiagnosed with cervical pregnancy and subsequently underwent selective uterine artery embolization and cervical mass excision. However, pathological examination revealed the diagnosis of cervical choriocarcinoma. Conclusion: This case highlights the propensity for misdiagnosis of cervical choriocarcinoma. Selective uterine artery embolization proves to be an efficient measure to manage hemorrhage and potentially avoid unnecessary hysterectomy.
oncology
What problem does this paper attempt to address?